Raymond James Initiates Coverage On AbbVie with Outperform Rating, Announces Price Target of $177
Portfolio Pulse from Benzinga Newsdesk
Raymond James analyst Gary Nachman has initiated coverage on AbbVie (NYSE:ABBV) with an Outperform rating and a price target of $177.
September 29, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Raymond James has initiated coverage on AbbVie with an Outperform rating and a price target of $177, which could positively impact the stock's performance.
Analyst ratings and price targets can significantly influence a stock's performance. In this case, Raymond James' Outperform rating and high price target for AbbVie suggest a positive outlook for the stock, which could drive its price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100